Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 152,168,320
  • Shares Outstanding, K 2,232,844
  • Annual Sales, $ 42,518 M
  • Annual Income, $ -9,015 M
  • 60-Month Beta 0.64
  • Price/Sales 3.61
  • Price/Cash Flow 6.18
  • Price/Book 4.00
Trade BMY with:

Options Overview

Details
  • Implied Volatility 17.23%
  • Historical Volatility 12.54%
  • IV Percentile 4%
  • IV Rank 0.14%
  • IV High 437.70% on 12/14/20
  • IV Low 16.64% on 06/16/21
  • Put/Call Vol Ratio 0.62
  • Today's Volume 2,811
  • Volume Avg (30-Day) 17,441
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 535,143
  • Open Int (30-Day) 514,933

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 1.94
  • Number of Estimates 5
  • High Estimate 1.98
  • Low Estimate 1.86
  • Prior Year 1.63
  • Growth Rate Est. (year over year) +19.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
65.78 +3.31%
on 07/19/21
69.27 -1.89%
on 07/29/21
+1.14 (+1.71%)
since 06/30/21
3-Month
62.65 +8.48%
on 05/03/21
69.27 -1.89%
on 07/29/21
+5.54 (+8.88%)
since 04/30/21
52-Week
56.75 +19.74%
on 10/29/20
69.27 -1.89%
on 07/29/21
+9.09 (+15.44%)
since 07/30/20

Most Recent Stories

More News
Virpax(R) Pharmaceuticals Strengthens Board of Directors with the Appointment of Gerald W. Bruce and Michael F. Dubin, CPA to its Board

Virpax(R) Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ: VRPX), a company specializing in developing pharmaceutical product candidates for pain management, today announced the appointment of...

VRPX : 4.60 (+1.90%)
JNJ : 172.58 (+0.23%)
BMY : 67.98 (-0.25%)
Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy

--Opdivo is now the first and only adjuvant therapy approved in this setting in the European Union

BMY : 67.98 (-0.25%)
Bristol-Myers' (BMY) Q2 Earnings Beat, Opdivo Sales Grow

Bristol-Myers (BMY) beats on earnings and sales in the second quarter as Opdivo sales revive.

BMY : 67.98 (-0.25%)
PFE : 42.85 (+0.14%)
RGEN : 245.57 (+1.90%)
AGEN : 5.17 (-0.39%)
Pfizer (PFE) Q2 Earnings Beat, View Up on COVID-19 Vaccine

Pfizer (PFE) beats second-quarter estimates for earnings and sales. It lifts its guidance for 2021.

BMY : 67.98 (-0.25%)
PFE : 42.85 (+0.14%)
AMGN : 243.02 (+0.23%)
BNTX : 324.09 (+3.68%)
Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Beat Estimates

Bristol Myers (BMY) delivered earnings and revenue surprises of 2.66% and 4.12%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

BMY : 67.98 (-0.25%)
Bristol Myers Squibb Reports Second Quarter Financial Results for 2021

Bristol Myers Squibb (NYSE:BMY) today reports results for the second quarter of 2021, which reflect robust product sales, continued advancement of the pipeline and strong clinical and operational performance...

BMY : 67.98 (-0.25%)
XLRN : 125.74 (-0.98%)
BLUE : 25.66 (+0.33%)
AGEN : 5.17 (-0.39%)
Top Analyst Reports for Comcast, Coca-Cola & Bristol-Myers Squibb

Today's Research Daily features new research reports on 16 major stocks, including Comcast (CMCSA), The Coca-Cola Company (KO), and Bristol-Myers Squibb (BMY).

BMY : 67.98 (-0.25%)
KO : 56.99 (-0.11%)
CMCSA : 58.93 (+1.41%)
CSCO : 55.34 (+0.49%)
AXP : 170.72 (-0.72%)
SYK : 271.59 (+0.90%)
Drug/Biotech Stock Earnings on Jul 28: PFE, GSK, BMY, BMRN & TLRY

Let us take a look at five drug/biotech companies - PFE, GSK, BMY, BMRN and TLRY - which are gearing up for their earnings release.

GSK : 40.11 (+0.02%)
NVS : 92.52 (+0.36%)
BIIB : 328.49 (-0.21%)
BMY : 67.98 (-0.25%)
JNJ : 172.58 (+0.23%)
PFE : 42.85 (+0.14%)
BMRN : 77.42 (-1.39%)
TLRY : 14.57 (-5.51%)
Is a Beat in Store for Bristol-Myers (BMY) in Q2 Earnings?

Investors will focus on regular top and bottom-line numbers along with key pipeline updates when Bristol-Myers (BMY) reports second-quarter 2021 results.

IRWD : 13.31 (+1.10%)
BMY : 67.98 (-0.25%)
PFE : 42.85 (+0.14%)
BLUE : 25.66 (+0.33%)
Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know

Bristol Myers Squibb (BMY) closed at $68.34 in the latest trading session, marking a +0.56% move from the prior day.

BMY : 67.98 (-0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in...

See More

Key Turning Points

3rd Resistance Point 70.15
2nd Resistance Point 69.71
1st Resistance Point 68.93
Last Price 67.98
1st Support Level 67.71
2nd Support Level 67.27
3rd Support Level 66.49

See More

52-Week High 69.27
Last Price 67.98
Fibonacci 61.8% 64.49
Fibonacci 50% 63.01
Fibonacci 38.2% 61.54
52-Week Low 56.75

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar